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Abstract
Introduction. The aim of our study was to compare the diagnostic accuracy achieved using different magnetic resonance 
(MR) techniques with the diagnostic accuracy achieved using transthoracic and transoesophageal echocardiography 
to detect intracardiac thrombi.
Materials and methods. Twenty-four patients with known or suspected intracardiac thrombi were examined using MR 
imaging and echocardiography. All MR examinations were performed on a 1.5-T MR scanner using dark-blood-prepared 
half-Fourier acquisition single-shot turbo spin-echo (HASTE) sequences, fast imaging steady-state free precession 
(trueFISP) cine sequences, and inversion recovery gradient-echo fast low-angle shot (inversion recovery turbo FLASH) 
sequences after injection of 0.2 mmoL/kg of gadolinium diethylene triamine pentaacetic acid (myocardial delayed 
enhancement).
Results. MR imaging and echocardiography revealed 12 thrombi as following: 2 in the right atrium, 1 in the right ventric-
le, 3 in the left atrium, and 6 in the left ventricle. Compared with echocardiography, MR imaging revealed 3 additional 
thrombi in the left ventricle; these thrombi were confirmed at surgery. All 15 thrombi appeared as filling defects on early 
contrast-enhanced inversion recovery turbo FLASH MR images. Only 7 thrombi were detected on HASTE images, and 10 
thrombi were seen on trueFISP images. Four thrombi showed enhancement 10–20 min after contrast material injection 
and were characterised as organised clots.
Conclusions. The contrast-enhanced inversion recovery turbo FLASH sequences (myocardial delayed enhancement) 
were superior to dark-blood-prepared HASTE and trueFISP cine MR images in revealing intracardiac thrombi. Compared 
with transthoracic echocardiography, MR imaging was more sensitive for the detection of left ventricular thrombi. The 
characterisation of thrombi may be used to predict the risk of embolism, which is higher for subacute clots than for 
organised thrombi.
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Introduction
Thrombi of the chambers of the left heart are a common 
source of stroke and other arterial embolic syndromes. 
Thrombi of the right heart are frequently detected in pa-
tients with pulmonary embolism [1, 2]. In clinical practice, 
transthoracic echocardiography is the diagnostic tool of first 
choice in such patients. However, the inability to visualise 
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(HASTE) sequence (TR/TE, 2 heartbeats/60 msec; flip an-
gle, 160°) covering the entire heart in the axial orientation. 
Thereafter, four-chamber and two-chamber views, as well 
as contiguous short-axis images of the entire heart were 
acquired with a fast imaging steady-state free precession 
(trueFISP) cine sequence (3 msec/1.5 msec; flip angle, 
60°). Images in the oblique orientation were obtained 
to further investigate the suspicious areas. Immediately 
after the injection of 0.2 mmol/kg of gadolinium diethylene 
triamine pentaacetic acid (Magnevist; Schering, Berlin, 
Germany) (flow rate, 2 mL/sec), breath-hold ECG-triggered 
2D inversion recovery turbo FLASH images (8/4; flip angle, 
25°) of four- and two-chamber views of the heart were 
acquired. Repeated three-dimensional (3D) inversion 
recovery turbo FLASH sequences (4/1.4; flip angle, 10°) 
in the short-axis orientation were then performed. In pa-
tients with suspicious findings, additional oblique slices 
were obtained, using either 2D or 3D inversion recovery 
turbo FLASH sequence. Images were acquired both imme-
diately after the injection of the contrast material and as 
long as 15 minutes after the injection (DE-CMR, delayed 
enhancement cardiac magnetic resonance). Whereas the 
2D sequence is a single-slice technique (slice thickness, 
8 mm), the 3D sequence can acquire as many as 24 slices 
with a slice thickness of 4 mm in one breath-hold of 
reasonable length, using a shorter TR, partial Fourier 
reconstruction (6/8), z-axis interpolation, and longer data 
acquisition window, with 77 k-space lines per heartbeat 
to improve the speed. The total imaging time required, 
including patient positioning, was 45–60 min. All the MR 
images were interpreted by an experienced radiologist 
who wasunaware of the diagnosis and of the results of 
the echocardiographic examinations. The interpretations 
for the HASTE, trueFISP, conventional DE-CMR andDE-CMR 
long inversion time were performed separately.
Results
Echocardiography revealed 12 intra-cardiac thrombi. The 
thrombi were located in the right atrium (n = 2), right ven-
tricle (n = 1), left atrium (n = 3), and left ventricle (n = 6). 
One thrombus in the appendage of the right atrium and 
two of the thrombi in the left atrium were visualised only on 
transoesophageal, not on transthoracic, echocardiography. 
All thrombi seen on echocardiography were detected on 
MR imaging. Cardiac MR imaging revealed three additional 
thrombi in the left ventricle not seen on transthoracic echo-
cardiography. None of these three patients had undergone 
transoesophageal echocardiography. Therefore, cardiac 
MR imaging revealed 15 thrombi in 24 patients. In seven 
patients, including three with discrepant findings, the MR 
imaging diagnosis was confirmed at surgery. The thrombi 
appeared isointense or slightly hyperintense relative to the 
myocardium on dark-blood-prepared HASTE images. Both 
all the cardiac chambers and the reduced image quality 
in patients who are not well suited for the procedure, are 
major limitations of transthoracic echocardiography. There-
fore, transoesophageal echocardiography has emerged 
as the most sensitive technique for the detection of in-
tracardiac thrombi and is believed to be the single best 
test for patients with suspected intracardiac thrombi [3]. 
However, distinguishing normal myocardium from clots may 
be difficult on echocardiography, hampering the diagnosis 
of thin mural thrombi. In addition, because of a lack of 
diagnostic criteria, differentiating subacute thrombi from 
organised thrombi on echocardiography — a distinction 
that is important in predicting the risk of embolic com-
plications — is challenging [4]. Within the last 10 years, 
magnetic resonance (MR) imaging has emerged as a new 
noninvasive cardiac imaging technique that can provide 
complementary information to the data obtained by echo-
cardiography in patients with various cardiac diseases. MR 
imaging can be considered the first-line imaging technique 
in patients with congenital heart disease and in those 
with suspected cardiac tumours. Recently, several new 
cardiac MR techniques have been introduced to improve 
spatial and temporal resolution, robustness, and contrast 
properties [5, 6] of the modality. These rapid technical 
developments have expanded the indications for cardiac 
MR imaging. The aim of our study was to evaluate the 
diagnostic accuracy achieved with different unenhanced 
and contrast-enhanced MR sequences for the detection 
of intracardiac thrombi and to compare the results with 
those achieved using transthoracic and transoesophageal 
echocardiography.
Materials and methods
After giving informed consent, 24 consecutive patients (17 
men and seven women; age range, 23–76 years; mean 
age ± standard deviation [SD], 57 ± 14 years), who had 
been referred to the echocardiography laboratory for eva-
luation of known or suspected intra-cardiac thrombi were 
enrolled in our study, which was performed in accordance 
with regulations set forth by the local institutional review 
board. The transthoracic echocardiography was performed 
in all the patients, and transoesophageal echocardiography 
was performed in 11 of 24 patients with suspected atrial 
thrombi. Two-dimensional (2D) echocardiographic exami-
nations were performed with state-of-the-art machines 
using standard views and techniques in accordance with 
the guidelines of the American Society of Echocardiography. 
The images were obtained with patients in the left lateral 
position at the end-expiration by experienced cardiologists.
A 1.5-T scanner (Siemens Medical Solutions, Erlangen, 
Germany) was used for all MR imaging. The MR imag-
ing protocol included an ECG-triggered dark-blood-pre-
pared half-Fourier acquisition single-shot turbo spin-echo 
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choice. The reasons include availability, high accuracy, and 
low cost. The technique is characterised by sensitivity and 
specificity values for left ventricular thrombi of approxi-
mately 90% compared with aneurysmectomy or autopsy 
[7]. Several studies have shown transoesophageal echo-
cardiography to be more sensitive for the detection of 
atrial thrombi than transthoracic echocardiography [3, 8], 
particularly for the detection of thrombi in the left atrial 
appendage. However, transoesophageal echocardiography 
is semi-invasive. The sensitivity of angiocardiography for 
the detection of intra-cardiac thrombus is unacceptably 
low, and indium-111 platelet scanning is time-consuming 
and expensive [7]. The contrast-enhanced CT is more 
sensitive for ventricular and atrial thrombi than transtho-
racic echocardiography, but the technique has been shown 
to be inferior to transoesophageal echocardiography for 
revealing atrial thrombi [9, 10]. These imaging techniques 
are of limited use in distinguishing between a thrombus 
and a cardiac tumour or in characterising a thrombus as 
acute or subacute. Over the years, cardiac MR imaging with 
different types of sequences has emerged as a noninvasive 
alternative for the detection and characterisation of in-
tra-cardiac masses [11–14]. In agreement with the earlier 
studies, the present study shows that the value of spin-echo 
and turbo spin-echo MR imaging sequences for revealing 
intra-cardiac masses is limited by artifacts caused by 
slow-flowing blood [11, 15]. Because of the high signal 
intensity inherent to blood, gradient-echo sequences are 
robust and more sensitive for the detection of intra-cardi-
ac thrombi. The differentiation of a mural thrombus from 
the myocardium can be challenging, however, recently 
of the right atrial thrombi, one of the left atrial thrombi, 
and four of nine left ventricular thrombi were detectable 
on HASTE images. The other eight thrombi were not visible 
on HASTE images because of poor contrast between the 
thrombus and the myocardium, and because of slow-flow 
artifacts, which hampered the establishment of the correct 
diagnosis, especially in patients with impaired ventricular 
function or left ventricular aneurysms. The thrombi showed 
low signal intensity on trueFISP cine images. Therefore, 
the differentiation of the myocardium from the thin mural 
thrombus was not possible on trueFISP images. Both right 
atrial thrombi, the only right ventricular thrombus, two left 
atrial thrombi, and five of nine left ventricular thrombi were 
detectable on trueFISP images. Delineation of thrombi wa-
sexcellent on both conventional DE-CMR and long inversion 
time DE-CMR. All thrombi appeared as low signal-intensity 
filling defects in the cavity and remaining dark signal inten-
sity on long inversion time DE-CMR (Figure 1).
Discussion
The ECG-triggered 3D inversion recovery turbo FLASH se-
quence provided excellent contrast and high spatial reso-
lution after the administration of an extracellular contrast 
agent, making this technique the most accurate to use for 
the detection of intra-cardiac thrombi. The 3D sequence 
allows full cardiac coverage in a single breath-hold and was 
shown to be well suited for revealing and characterising 
the intra-cardiac thrombi. Among the imaging techniques 
routinely used to visualise the intra-cardiac thrombi, 2D 
transthoracic echocardiography is the modality of first 
Figure 1A–C. Representative examples of LV thrombus assessment by CMR. Intracavitary thrombus within LV apex (arrow), despite nega-
tive transthoracic echocardiography. Note that thrombus appears “etched” on trueFISP SSFP (A) and standard DE-CMR (B; inversion time 
250–350 msec) and homogenously black in a long inversion time (C; inversion time = 600 msec) imaging. The patient surgical resection 
enabled thrombus verification based on histopathology (not shown)
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developed trueFISP sequence used in the present study 
improves the contrast between the myocardium and blood 
[6], but thrombi are isointense relative to the myocardium, 
so the diagnosis of mural thrombi may be hampered. The 
intravenous administration of gadolinium diethylene tri-
amine pentaacetic acid with DE-CMR sequence was shown 
to enhance the contrast between the myocardium and 
thrombi, thereby improving our ability to detect and chara-
cterise the thrombi [4, 14]. DE-CMR is a technique widely 
used to differentiate between infarcted and viable myocar-
dium, based on relative differences in gadolinium-based 
contrast uptake and can be used to identify thrombus. 
Whereas gadolinium-based contrast agents demonstrate 
uptake within infarcted myocardium, thrombus manifests 
an absence of gadolinium uptake due to its avascular 
composition [4]. On DE-CMR, thrombus appears as a low 
signal intensity mass (attributable to the absence of con-
trast uptake) surrounded by high signal intensity (i.e., 
contrast-enhanced) structures, such as cavity blood and/ 
/or surrounding myocardium. The absence of contrast 
enhancement can be used to distinguish thrombus from 
other masses such as neoplasm, which typically demon-
strate contrast uptake due to tumour-associated vascula-
rity. On conventional DE-CMR, which is tailored to null via-
ble myocardium (typical inversion time 200–300 msec), 
thrombus appears grey or “etched,” viable myocardium 
black, and infarcted myocardium white. Both, viable myo-
cardium and thrombus, can appear relatively dark and may 
be difficult to distinguish from one another. DE-CMR can 
be further tailored for thrombus assessment by prolonging 
the inversion time (i.e., 600 msec) to selectively null avas-
cular tissue such as thrombus. This so-called “long inver-
sion time” approach produces an image that renders 
thrombus black and surrounding myocardium bright [4]. 
The present study suggests that the DE-CMR is optimally 
suited for imaging cardiac thrombi. Inversion times can be 
varied to improve the contrast between the thrombi and 
the myocardium. The signal intensity of myocardial infarc-
tions, which are frequently associated with left ventricular 
thrombi, increases over time, permitting easy differentia-
tion between the nonviable infarcted tissue and the throm-
bi. A recently developed ECG-triggered 3D inversion recove-
ry turbo FLASH sequence even allows full cardiac coverage 
in a single breath-hold and seems ideally suited for the 
detection of intra-cardiac thrombi. However, the use of ECG 
triggering is a prerequisite for obtaining high-quality ima ges. 
Although not present in our study, artifacts may occur in 
patients with atrial fibrillation or other arrhythmias, which 
are frequently associated with intra-cardiac thrombi. In-
tra-cardiac thrombi are associated with a variety of disea-
ses. Functional disorders such as myocardial infarction or 
atrial fibrillation are a common cause of cardiac thrombi 
[7, 16]. The frequency of left ventricular thrombi is approxi-
mately 30% in patients with an acute or healed myocardial 
infarction. Most thrombi develop within the first week after 
the infarction and are most often noted at the apex of the 
left ventricle in patients who have had an anterior myocar-
dial infarction [7]. Deep vein thrombosis or the use of 
central venous catheters may lead to development of 
thrombi in the right heart, which should be considered 
pulmonary emboli in transit [1, 17–19]. Chronic anabolic 
steroid abuse, as well as several disorders and diseases, 
such as Behçet’s syndrome, coagulopathies, Löffler’s en-
docarditis, Churg-Strauss syndrome, or right atrial aneu-
rysm should be considered potential causes of intracar diac 
thrombi [20–24]. In these rare clinical settings, the differen-
tiation between thrombi and cardiac tumours can be 
challenging [21, 24], and MR imaging may provide addi-
tional information to that obtained from echocardiography. 
The intracardiac thrombi may cause arterial or pulmonary 
embolisms and should be regarded as life-threatening. It 
is estimated that in approximately 30% of cases of cerebral 
infarction, the causative thrombus originated in the heart 
[2, 3]. Cardiac diseases or abnormalities that may cause 
arterial emboli include atrial and ventricular thrombosis, 
cardiac tumours, thrombosis on heart valve prostheses, 
and endocarditis [8]. The present study indicate that con-
trast-enhanced MR imaging depicts intracardiac thrombi 
more accurately than transthoracic echocardiography does 
and is as sensitive as transoesophageal echocardiography. 
Cardiac MR imaging is the most accurate imaging moda lity 
in patients with suspected cardiac tumours. However, 
cardiac MR imaging cannot replace echocardiography in 
patients who have had a cerebral stroke, because endo-
carditis, thrombosis on heart valve prostheses, and other 
potential sources of embolism such as patent foramen 
ovale, valve strands, atrial septum aneurysm, and dystro-
phy of mitral annulus are difficult to visualise on MR ima-
ging. In patients with a pulmonary embolism, the rare 
finding of right heart thrombi may be underdiagnosed. The 
clinical studies using echocardiography and autopsy stud-
ies suggest that these thrombi occur in 6–18% of patients 
with a pulmonary embolism [25–27]. Most of these pa-
tients cannot undergo MR imaging, because they present 
with severe dyspnea or cardiogenic shock [1, 26]. Trans-
oeso phageal echocardiography is unquestionably the 
ima ging technique of first choice in suchpatients. The use 
of MR imaging should be restricted to clinically stable pa-
tients, who have either no symptoms or only minor ones, 
and in whom potential differential diagnoses, like intra-car-
diac tumours and congenital structures such as Chiari’s 
network or persistent eustachian or thebesian valves 
cannot be excluded with certainty. In addition, cardiac MR 
imaging may be combined with pulmonary MR angiography 
[28] to provide a single test for the pulmonary vasculature 
and heart in patients with suspected pulmonary embolism. 
The risk of embolism depends on morphologic parameters 
that can easily be assessed on echocardiography and MR 
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imaging. The embolic risk is approximately 50% for mobile 
or protruding thrombi compared with an embolic risk of 
approximately 10% for non-mobile or flat thrombi [7]. The 
MR imaging can distinguish subacute clots, which do not 
enhance after the contrast material injection from the or-
ganised thrombi [4]. Four of the 15 thrombi in the present 
study showed significant enhancement and could be 
considered organised clots. Such characterisation provides 
more information than echocardiography does and may be 
of great clinical interest, because embolic complications 
are more likely to occur with subacute clots than with or-
ganised thrombi.
Conclusions
Echocardiography remains the imaging modality of choice 
in patients with suspected intracardiac thrombi. However, 
the present study shows that ECG-triggered contrast-en-
hanced cardiac MR imaging is emerging as an accurate 
noninvasive alternative technique for the detection and 
characterisation of intracardiac thrombi.
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Streszczenie
Wstęp. Celem pracy było porównanie dokładności diagnostycznej różnych technik badania rezonansu magnetycznego 
(MRI) z dokładnością diagnostyczną echokardiografii przezklatkowej i przezprzełykowej w wykrywaniu skrzeplin we-
wnątrzsercowych.
Materiały i metody. Dwudziestu czterech chorych, u których potwierdzono lub podejrzewano skrzeplinę wewnątrzserco-
wą, poddano badaniom metodami MRI i echokardiografii. Wszystkie badania MRI przeprowadzono za pomocą skanera 
MR 1,5 T, stosując następujące techniki: szybkie zmodyfikowane sekwencje echa spinowego, tak zwane sekwencje 
czarnej krwi — HASTE (half-Fourier acquisition single-shot turbo spin-echo); szybkie sekwencje filmowe (cine) trueFISP 
(fast imaging steady-state free precession) oraz sekwencje echa gradientoweg typu FLAH (fast low-angle shot) z impul-
sem inwersyjnym po wstrzyknięciu 0,2 mmol/kg mc. kontrastu gadolin–kwas dietylenotriaminopentaoctowy (opóźnione 
wzmocnienie kontrastowe miokardium).
Wyniki. Obecność 12 skrzeplin ujawniono zarówno w badaniach MRI, jak i echokardiograficznych: 2 w prawym przed-
sionku, 1 w prawej komorze, 3 w lewym przedsionku i 6 w lewej komorze. W porównaniu z echokardiografią badania 
MRI pozwoliły uwidocznić 3 dodatkowe skrzepliny w lewej komorze. Obecność tych skrzeplin potwierdzono w trakcie 
zabiegu chirurgicznego. Wszystkie 15 skrzeplin było widocznych jako defekt napełniania komory na obrazach wczesnej 
fazy wzmocnienia kontrastowego sekwencji turbo FLASH z impulsem inwersyjnym. Na obrazach wykonanych techniką 
HASTE widocznych było tylko 7 skrzeplin, a na obrazach wykonanych techniką trueFISP — 10 skrzeplin. W przypadku 
4 skrzeplin stwierdzono wzmocnienie kontrastowe 10–20 min po podaniu środka kontrastowego i scharakteryzowano 
je jako skrzepliny zorganizowane.
Wnioski. Sekwencje turbo FLASH z impulsem inwersyjnym (opóźnione wzmocnienie kontrastowe miokardium) były 
bardziej skuteczne w uwidocznianiu skrzeplin wewnątrzsercowych niż obrazy uzyskane techniką ciemnej krwi HASTE 
i sekwencje cine trueFISP. Badania MRI cechowały się większą czułością w wykrywaniu skrzeplin umiejscowionych 
w lewej komorze serca. Scharakteryzowanie cech skrzepliny może być przydatne w predykcji ryzyka zatoru, które jest 
wyższe w przypadku skrzeplin podostrych niż skrzeplin zorganizowanych.
Słowa kluczowe: MRI serca, skrzeplina w sercu
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